Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Tübingen, Universität Tübingen, Dissertation, 2017
- Keyword
-
Liver--Cancer
Measles vaccine
Histone deacetylase
Tumor ; Onkologie ; Viren ; Epigenetik ; Leberkrebs
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2017
- Creator
- Contributor
-
Lauer, Ulrich
- URN
-
urn:nbn:de:bsz:21-dspace-790589
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ruf, Benjamin
- Lauer, Ulrich
- Universitätsbibliothek Tübingen
Time of origin
- 2017
Other Objects (12)
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma